Seeing Is Believing
Analyst Chris Cooper, currently employed at GOLDMAN SACHS,
Most recent stock forecast was given on RMD, ResMed at 10-May-2025.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$290
$50.05 (20.86%)
$286
16 days ago
(24-Apr-2025)
14/18 (77.78%)
$53.9 (22.83%)
310
Hold
$248
$8.05 (3.35%)
$260
16 days ago
(24-Apr-2025)
1/3 (33.33%)
$11.9 (5.04%)
17
Buy
$285
$45.05 (18.77%)
$250
16 days ago
(24-Apr-2025)
5/6 (83.33%)
$48.9 (20.71%)
30
Hold
3 months 9 days ago
(31-Jan-2025)
11/11 (100%)
$-7.67 (-3.15%)
212
Buy
$250
$10.05 (4.19%)
$215
7 months 10 days ago
(30-Sep-2024)
11/11 (100%)
$6.95 (2.86%)
115